Learn More
BACKGROUND Assessing the state of country readiness for the introduction of new, child-friendly anti-tuberculosis formulations can highlight potential bottlenecks, facilitate early planning, and accelerate access to appropriate treatment for children with tuberculosis (TB). METHODS To understand pathways and potential obstacles to the introduction of new(More)
  • 1